Romidepsin


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 33.2%
Drug Use For Unknown Indication 14.2%
Peripheral T-cell Lymphoma Unspecified 9.9%
Constipation 6.7%
Pain 5.9%
T-cell Lymphoma 5.1%
Nausea 4.3%
Cancer Pain 2.4%
Hypertension 2.4%
Multiple Myeloma 2.4%
Supplementation Therapy 2.4%
Antiemetic Supportive Care 1.6%
Mycosis Fungoides Refractory 1.6%
Dry Skin 1.2%
Hypothyroidism 1.2%
Lymphoma 1.2%
Mycosis Fungoides 1.2%
Peripheral T-cell Lymphoma Unspecified Recurrent 1.2%
Prophylaxis 1.2%
Chronic Lymphocytic Leukaemia 0.8%
Hepatitis B 11.4%
Vomiting 11.4%
Thrombocytopenia 9.1%
Death 6.8%
Lymphoma 6.8%
Tendon Disorder 6.8%
Troponin Increased 6.8%
Atrial Flutter 4.5%
Diarrhoea 4.5%
Gastrointestinal Haemorrhage 4.5%
Mental Status Changes 4.5%
Peripheral T-cell Lymphoma Unspecified 4.5%
Adult T-cell Lymphoma/leukaemia Refractory 2.3%
Blood Creatinine Increased 2.3%
Blood Urea Increased 2.3%
Deep Vein Thrombosis 2.3%
Dyspepsia 2.3%
Fatigue 2.3%
Graft Versus Host Disease 2.3%
Hodgkin's Disease 2.3%
Secondary
Product Used For Unknown Indication 22.3%
T-cell Lymphoma 21.7%
Drug Use For Unknown Indication 10.2%
Peripheral T-cell Lymphoma Unspecified 8.2%
Pain 5.2%
Supplementation Therapy 4.9%
Multiple Myeloma 4.6%
Prophylaxis 3.8%
Plasma Cell Myeloma 3.2%
Constipation 2.5%
Antiemetic Supportive Care 2.2%
Antifungal Treatment 2.2%
Nausea 1.7%
Antacid Therapy 1.5%
Premedication 1.2%
Analgesic Therapy 0.9%
Cancer Pain 0.9%
Hypertension 0.9%
Infection Prophylaxis 0.9%
T-cell Prolymphocytic Leukaemia 0.9%
Haematotoxicity 20.3%
Hepatic Enzyme Increased 16.9%
Hepatitis B 8.5%
Herpes Virus Infection 8.5%
Dermatitis Exfoliative 5.1%
Troponin Increased 5.1%
Atrial Flutter 3.4%
Electrocardiogram T Wave Amplitude Decreased 3.4%
Gastrointestinal Haemorrhage 3.4%
Lymphoma 3.4%
Pyrexia 3.4%
Thrombocytopenia 3.4%
Vomiting 3.4%
Acute Coronary Syndrome 1.7%
Acute Pulmonary Oedema 1.7%
Arrhythmia 1.7%
Atrial Fibrillation 1.7%
Clostridium Difficile Colitis 1.7%
Cytokine Release Syndrome 1.7%
Cytomegalovirus Chorioretinitis 1.7%

Drug Data